Isolation and characterization of a novel gene from human glioblastoma multiforme tumor tissue

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 565-572

  Sehgal, Anil ^a,d   Keener, Cassie ^a   Boynton, Alton L ^a   Young, Ronald F ^a,b   Vermeulen, Sandra S ^a   Yonemura, Kenneth S ^b   Kohler, Erik P ^a,c   Aldape, Hector C ^a   Simrell, Charles R ^a   Murphy, G P ^a  

^a NORTHWEST HOSPITAL   (United States)

^b Northwest Neuroscience Institute   (United States)

^c Puget Sound Sage   (United States)

^d PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN TUMOR; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE ISOLATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ASTROCYTES; BASE SEQUENCE; BRAIN NEOPLASMS; GENES; GLIOBLASTOMA; HELA CELLS; HL-60 CELLS; HUMANS; LYMPHOMA, B-CELL; MENINGEAL NEOPLASMS; MENINGIOMA; MOLECULAR SEQUENCE DATA; NEOPLASMS; POLYMERASE CHAIN REACTION; SUBTRACTION TECHNIQUE; TUMOR CELLS, CULTURED;

EID: 0030950347     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<565::AID-IJC10>3.0.CO;2-B     Document Type: Article

References (22)

1. ANGEL, P. and KARIN, M., The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. biophys. Acta, 1072, 129-157 (1991).
2. BAUER, D., MÜLLER, H., REICH, J., RIEDEL, H., AHRENKIEL, V., WARTHOE, P. and STRAUSS, M., Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res., 21, 4272-4280 (1993).
3. BOGLER, O., HUANG, J.-J.S., KLEIHUES, P. and CAVENEE, W.K., The p53 gene and its role in human brain tumors. Glia, 15, 308-327 (1995).
4. CHEN, J., WILLINGHAM, T., MARGRAF, L.R., SCHREIBER-AGUS, N., DEPINHO, R.A. and NISEN, P.D., Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nature (Med.), 1, 638-643 (1995).
5. EIBL, R.H., PIETSCH, T., MOLL, J., SKROCH-ANGEL, P., HEIDER, K.-H., VON AMMON, K., WIESTLER, O.D., PONTA, H., KLEIHUES, P. and HERRLICH, P., Expression of variant CD44 epitopes in human astrocytic brain tumors. J. Neurooncol., 26, 165-170 (1995).
6. FAILLOT, T., MAGDELÉNAT, H., MADY, E., STASIECKI, P., FOHANNO, D., GROPP, P., POISSON, M. and DELATTRE, J.Y., A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas. Neurosurgery, 39, 478-483 (1996).
7. FURNARI, F.B., HUANG, H.J. and CAVENEE, W.K., Genetics and malignant progression of human brain tumours. Cancer Surv., 25, 233-275 (1995).
8. HADMAN, M., ADAM, B.-L., WRIGHT, G.L., JR. and BOS, T.J., Modifications to the differential display technique reduce background and increase sensitivity. Anal. Biochem., 226, 383-386 (1995).
9. IKONOMOV, O.C. and JACOB, M.H., Differential display protocol with selected primers that preferentially isolates mRNAs of moderate- to low-abundance in a microscopic system. Biotechniques, 20, 1030-1042 (1996).
10. WAFI/Cip1 in human brain tumors. Oncogene, 11, 2021-2028 (1995).
11. LIANG, P., AVERBOUKH, L., KEYOMARSI, K., SAGER, R. and FARDEE, A.B., Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res., 52, 6966-6968 (1992).
12. LIANG, P. and PARDEE, A.B., Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971 (1992).
13. NISHIO, Y., AIELLO, L.P. and KING, G.L., Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display. FASEB J., 8, 103-106 (1994).
14. PARKER, L., TONG, T., BOLDEN, S. and WINGO, P.A., Cancer statistics, 1996. CA Cancer J. Clin., 46, 5-28 (1996).
15. PREVITALI, S., QUATTRINI, A., NEMNI, R., TRUCI, G., DUCATI, A., WRABETZ, L. and CANAL, N., αβ64 and αβ61 integrins in astrocytomas and other CNS tumors. J. Neuropathol. exp. Neurol., 55, 456-465 (1996).
16. SAMBROOK, J., FRITSCH, E. and MANIATIS, T., Molecular cloning: a laboratory manual, (2nd ed.), Cold Spring Harbor Laboratory, NY (1989).
17. SEHGAL, A., PRESENTE, A., DUDUS, L. and ENGELHARDT, J.F., Isolation of differentially expressed cDNAs during ferret tracheal development: application of differential display PCR. Expelling Res., 22, 419-434 (1996).
18. TAKANO, S., YOSHII, Y., KONDO, S., SUZUKI, H., MARUNO, T., SHIRAI, S. and NOSE, T., Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res., 56, 2185-2190 (1996).
19. THAPAR, K. and LAWS, E.R., Brain tumors. CA Cancer J. Clin., 43, 263-271 (1993).
20. TSUZUKI, T., TSUNODA, S., SAKAKI, T., KONISHI, N., HIASA, Y. and NAKAMURA, M., Alterations of retinoblastoma, p53, p16 (CDKN2), and p15 genes in human astrocytomas. Cancer. 78, 287-293 (1996).
21. YAMAMOTO, M., MOHANAM, S., SAWAYA, R., FULLER, G.N., SEIKI, M., SATO, H., GOKASLAN, Z.L., LIOTTA, L.A., NICOLSON, G.L. and RAG, J.S., Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res., 56, 384-392 (1996).
22. YEATMAN, T.J. and MAO, W., Identification of a differentially-expressed message associated with colon cancer liver metastasis using an improved method of differential display. Nucleic Acids Res., 23, 4007-4008 (1995).